Option Care Health (OPCH): insider & executive buying
Option Care Health · Health Care · ref. ETF XLV · price $23.98
In short — 4 insiders bought Option Care Health over ~6 months (4 buys, total $1.9M, latest May 7, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are Option Care Health's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$23.98-16.6% over range
Aug 28, 25low $19.52 · high $36.59Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
50% recommend buying · 8 analysts
Latest insider buys on Option Care Health
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 7, 26 | Sullivan Timothy P | Dir | 24,154 | $500k |
| May 4, 26 | Kraemer Harry M Jansen Jr | Dir | 36,610 | $784k |
| May 4, 26 | Sethna Meenal | CFO | 16,225 | $327k |
| May 4, 26 | Rademacher John Charles | CEO | 12,500 | $265k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Option Care Health's executives bought shares recently?
4 Option Care Health insider(s) bought $1.9M over ~6 months (latest May 7, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for OPCH?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Option Care Health? The JPI assistant answers using our backtest data.
Keep exploring Option Care Health